Mary Van Beusekom | News Writer | CIDRAP NewsMay 28, 2020An international study found similar results with either a 5-day or 10-day course of the antiviral drug.
5 days of remdesivir for COVID-19 may be enough
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows